PE-conjugated Anti-CD22 (pinatuzumab biosimilar) mAb

Größe

£290.00

SKU:: BME100029P
Zusätzliche Namen:: ACD22-VCMMAE; DCDT2980S; FCU2803; RG-7593; RO5541072-000
Lagerbedingungen:: Store at 2[o]C-8[o]C for 6 months
Hersteller:: DIMA Biotechnology Ltd
Host:: Human
Reaktivitäten:: Human
Formulierung:: Liquid PBS with 0.05% Proclin300; 1% BSA
Target:: CD22
Weitere Details:: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.